{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:29:37Z","timestamp":1765546177086},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.034","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T17:30:38Z","timestamp":1486056638000},"page":"1281-1286","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010\u20132014"],"prefix":"10.1016","volume":"35","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.034_b0005","unstructured":"WHO. Polio vaccines: WHO position paper, March 2016. WER 2016, vol. 91. p. 145\u2013168."},{"key":"10.1016\/j.vaccine.2017.01.034_b0010","series-title":"OW Plotkin SA, Vaccines","first-page":"598","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2013"},{"key":"10.1016\/j.vaccine.2017.01.034_b0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-695X.2009.00621.x","article-title":"Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary","volume":"58","author":"Kapusinszky","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.01.034_b0020","unstructured":"Polio Global Eradication Initiative. Circulating vaccine-derived poliovirus [EB\/OL]. Available at <http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/circulating-vaccine-derived-poliovirus\/>; September, 2016."},{"issue":"suppl 1","key":"10.1016\/j.vaccine.2017.01.034_b0025","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.034_b0030","unstructured":"Polio Global Eradication Initiative. Polio eradication and endgame strategic plan 2013-2018[EB\/OL]. Available at <http:\/\/www.Polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/Peesp_ES_EN_A4.pdf>; May 8, 2013."},{"key":"10.1016\/j.vaccine.2017.01.034_b0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1539-6924.2012.01891.x","article-title":"Modeling population immunity to support efforts to end the transmission of live polioviruses","volume":"33","author":"Thompson","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2017.01.034_b0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress toward polio eradication - worldwide, 2015\u20132016","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"492\u2013498","key":"10.1016\/j.vaccine.2017.01.034_b0045","first-page":"546","article-title":"Immunization coverage of the national immunization program vaccines at the township level, based on a survey conducted by provincial CDCs in China, 2013","volume":"20","author":"Zheng","year":"2014","journal-title":"Chin J Vaccine Immun"},{"key":"10.1016\/j.vaccine.2017.01.034_b0050","first-page":"88","article-title":"Comparison of national immunization program childhood vaccine coverage determined by the children\u2019 s immunization information management system with coverage determined by field investigation","volume":"21","author":"Chen","year":"2015","journal-title":"Chin J Vaccine Immun"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.01.034_b0055","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1093\/infdis\/jit838","article-title":"Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation","volume":"210","author":"Duintjer Tebbens","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.034_b0060","first-page":"201","article-title":"Surveillance of Vaccine -associated Paralytic Poliomyelitis in Beijing, 1989\u20132002","volume":"9","author":"Liu","year":"2003","journal-title":"Chin J Vaccine Immun"},{"key":"10.1016\/j.vaccine.2017.01.034_b0065","series-title":"Cross-sectional study of the usage of polio vaccine in five vaccination clinic in H city","first-page":"20","author":"Hu","year":"2014"},{"key":"10.1016\/j.vaccine.2017.01.034_b0070","first-page":"1","article-title":"Insidious reintroduction of wild poliovirus into Israel, 2013","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surv"},{"key":"10.1016\/j.vaccine.2017.01.034_b0075","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/infdis\/jiu674","article-title":"Modeling options to manage type 1 wild poliovirus imported into Israel in 2013","volume":"211","author":"Kalkowska","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.034_b0080","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa1303368","article-title":"Identification and Control of a Poliomyelitis Outbreak in Xinjiang, China","volume":"369","author":"Luo","year":"2013","journal-title":"N Engl J Med"},{"issue":"361\u2013364","key":"10.1016\/j.vaccine.2017.01.034_b0085","first-page":"368","article-title":"Emergency response to the outbreak of imported wild poliovirus in Xinjiang Uygur Autonomous Region in 2011: experience and lessons","volume":"19","author":"Yu","year":"2013","journal-title":"Chin J Vaccines Immun"},{"key":"10.1016\/j.vaccine.2017.01.034_b0090","first-page":"487","article-title":"A baseline survey of Guardian\u2019s awareness of introducing inactivated poliovirus vaccine into the national immunization program pilot provinces","volume":"22","author":"Yu","year":"2016","journal-title":"Chin J Vaccines Immun"},{"key":"10.1016\/j.vaccine.2017.01.034_b0095","first-page":"699","article-title":"Eradication Initiative. Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine\u2014worldwide, 2013\u20132016","volume":"64","author":"Immunization Systems Management Group of the Global Polio","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.01.034_b0100","unstructured":"WHO. Meeting of the Strategic Advisory Group of Experts on immunization, April 2016\u2013 conclusions and recommendations. WER 2016, vol. 91, p. 265\u201384."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:31:34Z","timestamp":1536067894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X1730083X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010\u20132014","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}